Skip to Main Content

Our Team • Leadership

LEADERSHIP

Michael A. Foley, PhD Michael A. Foley, PhD
Sanders Director
The Institute’s first director, Dr. Foley is an accomplished chemist and entrepreneur with more than 25 years of industry and academic experience. He has been scientific co-founder of four companies and one academic institute and has placed twelve single agent or combination drugs into clinical development. He was most recently the Director of the Chemical Biology Platform at the Broad Institute of Harvard and MIT, which successfully established over 150 high throughput screening development collaborations under his leadership. Dr. Foley previously worked at Bristol-Myers Squibb and GlaxoSmithKline, and obtained his PhD in chemistry at Harvard.


BOARD OF DIRECTORS

Current Members

Augustine M.K. Choi, MDAugustine M.K. Choi, MD
Interim Dean, Weill Cornell Medicine
Interim Provost for Medical Affairs, Cornell University
Weill Chairman, Joan and Sanford I. Weill Department of Medicine

Barry Coller, MDBarry Coller, MD
David Rockefeller Professor
The Rockefeller University

Richard P. Lifton, M.D., Ph.D.Richard P. Lifton, MD, PhD
President
The Rockefeller University

Carl Nathan, MDCarl Nathan, MD
Chairman of Microbiology and Immunology
Weill Cornell Medicine

David Scheinberg, MD, PhDDavid Scheinberg, MD, PhD
Chairman of Molecular Pharmacology and Chemistry Program
Memorial Sloan Kettering Cancer Center

Craig B. Thompson, MDCraig B. Thompson, MD
President and CEO
Memorial Sloan Kettering Cancer Center

Emeritus

LaLaurie Glimcher, MDLaurie H. Glimcher, MD
President of Dana-Farber Cancer Institute

Marc Tessier-Lavigne, PhDMarc Tessier-Lavigne, PhD
President
Stanford University


Tri-I TDI Small Molecule Scientific Advisory Board

Internal Members

Neal Rosen, MD, PhD
Enid A.Haupt Chair in Medical Oncoloy
Memorial Sloan Kettering Cancer Center

Derek Tan, PhD
Director, Tri-Institutional PhD Program in Chemical Biology
Memorial Sloan Kettering Cancer Center

Sean Brady, PhD
Investigator, Howard Hughes Medical Institute
Evnin Associate Professor
Laboratory of Genetically Encoded Small Molecules
The Rockefeller University

Hermann Steller, PhD
Strang Professor
Strang Laboratory of Apoptosis and Cancr Biology
The Rockefeller University

Paraskevi (Evi) Giannakakuo, PhD
Professor of Pharmacology in Medicine
Director of Laboratory Research
Division of Hematology and Medical Oncology
Weill Cornell Medicin

Gregory Petsko, PhD
Arthur J. Mahon Professor of Neurology and Neuroscience
Weill Cornell Medicine

External Members

Mark Murcko, PhD*
SVP, Strategy, Schrödinger
Chief Technology Officer & Chair of the Scientific Advisory Board, Vertex Pharmaceuticals

Liam Ratcliff, PhD
Managing Director, New Leaf Venture Partners
Sr. VP Pfizer Global R&D

Joseph Vacca, PhD
Head of Early Success Sharing Partnerships, WuXi AppTec
Medicinal Chemistry Lead, Merck Research Labs

Kathleen Metters, PhD
President, Black Combe Consulting, Ltd.
Sr. VP External Discovery & Preclinical Sciences, Merck

Takeda Members

Juan Harrison
Vice President, New Frontier Science
Takeda Pharmaceuticals International

Steve Hitchcock, PhD
Chief Scientist and Site Head, Takeda California

EMERITI

Jim Neidel, PhD
Managing Director, New Leaf Venture Partners
Head of WW R&D, Glaxo Welcome

Nancy Thornberry
Senior Vice President and Franchise Head, Diabetes and Endocrinology
Merck Research Labs

Charles M. Rice, PhD
Maurice R. and Corinne P. Greenberg Professor in Virology
Laboratory of Virology and Infectious Disease
The Rockefeller University

Ari Melnick, MD
Gebroe Family Professor of Hematology/Oncology
Weill Cornell Medicine

James Fagin, MD
Chief, Endocrinology Service
Memorial Sloan Kettering Cancer Center


Tri-I TDI Antibody Scientific Advisory Board

Internal Members

Renier Brentjens, MD, PhD
Medical Oncologist, Director, Cellular Therapeutics
Memorial Sloan Kettering Cancer Center

Paul Chapman, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center

Michel Nussenzweig, MD, PhD
Zanvil A. Cohn and Ralph M. Steinman Professor 
Laboratory of Molecular Immunology
The Rockefeller University

Jeffrey Ravetch, MD, PhD
Theresa and Eugene M. Lang Professor 
Leonard Wagner Laboratory of Molecular Genetics and Immunology
The Rockefeller University

David Artis, PhD
Michael Kors Professor in Immunology
Professor of Immunology in Medicine & Microbiology and Immunology
Weill Cornell Medicine

John Moore, PhD
Professor of Microbiology and Immunology
Weill Cornell Medicine

External Members

Joel Scherer, MD*
Managing Director and CMO,
Lily Chorus

Paul J. Maddon, PhD
Founder, Progenics Pharmaceuticals, Inc.

David Grayzel, MD
Partner, Atlas Ventures
Arteus Therapeutics, LLC, CEO & Director

Larry Green, PhD
CEO, Ablexis, LLC

Takeda Members

Juan Harrison
Vice President, New Frontier Science
Takeda Pharmaceuticals International

Steve Hitchcock, PhD
Chief Scientist and Site Head, Takeda California

EMERITI

Stephen Squinto, PhD
Partner OrbiMed Healthcare Fund Management,
Alexion, Co-Founder and Chef Global Operations Officer

*Chair

LEADERSHIP Michael A. Foley, PhDSanders DirectorThe Institute’s first director, Dr. Foley is an accomplished chemist and entrepreneur with more than 25 years of industry and academic exper